Keep up to date
- Press release | 22.01.2018
Univercells to receive €2.4M from Walloon Region for its “Universimilar” program
New endowment to open avenues for the development of Univercells’ innovative antibody manufacturing platform – its ultimate goal being to ...
- Univercells news | 21.12.2017
Season’s greetings from Univercells
The best is yet to come...
- Press release | 15.12.2017
Univercells secures €3M Series A2 funding
This capital injection will help accelerate the development and commercialization of the company’s technology platforms and innovative solutions
- Univercells news | 08.11.2017
Univercells joins the Belgian State Visit to India
Hugues Bultot, CEO of Univercells, joins the Belgian business delegation to further develop collaborative efforts and...
- Univercells news | 28.09.2017
Univercells Excellence Award
Congratulations to Aline Jordens, valedictorian and laureate of the excellence award delivered by David Louvet. The proclamation ceremony of the ...
- Press release | 12.09.2017
Doug Neugold appointed Chairman of the Board
Mr. Neugold, a seasoned executive with extensive industry experience in single-use bioprocess solutions, has been appointed as chairman of our ...
- In the press | 02.08.2017
José Castillo, CTO of Univercells (French)
Notre CTO, José Castillo, revient sur son parcours d'entrepreneur lors d'un entretien pour G Square, le magazine de l'Ecole polytechnique ...
- Univercells news | 02.06.2017
Expansion of our laboratory area
Driven by our recent successes, Univercells has grown fast over the last few months. To accommodate the ever-expanding work at ...
Download Univercells company profile, logo, and picturesPress kit
Belgium Press Inquiries
Univercells - Marketing & Communication firstname.lastname@example.org
International Press Inquiries
Andrew Lloyd - Juliette Dos Santosjuliette@ala.com
“Disruptive micro-facility for affordable vaccines manufacturing” Benjamin DAMIEN
“Innovative cell culture and purification approaches applied to cost-effective manufacturing of vaccines” Benjamin DAMIEN
MIT Vaccines Bioprocess Development Commercialization Workshop
"Innovative USP & DSP approaches
applied to viral vaccines" José CASTILLO